Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leo

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2005
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trialP Comella, B Massidda, G Filippelli, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 27, 2018
[Analysis of causes of destruction of labile blood products in health institutions: A multicentric study]A Damais-Cepitelli, S Leo-Kodeli, V Lovi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2020
Reducing hospital admissions for COVID-19 at a dedicated screening centre in SingaporeG S E Tan, H Ang, C M Manauis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trialP Comella, F De Vita, S Mancarella, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 17, 2007
[Assessment of knowledge in blood transfusion of medical staff in 14 state-run hospitals]H Gouëzec, V Bergoin, V Betbèze, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2015
Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 scoreA Faggiano, A C Carratù, E Guadagno, et al.
Lancet (London, England)|October 16, 1999
Outbreak of Nipah-virus infection among abattoir workers in SingaporeN I Paton, Y S Leo, S R Zaki, et al.
JAMA|July 13, 2000
Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window periodA E Ling, K E Robbins, T M Brown, et al.
International Journal of Oncology|September 2, 2014
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III studyV Lorusso, F Giotta, R Bordonaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trialN Normanno, R Esposito Abate, M Lambiase, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2005
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trialP Comella, B Massidda, G Filippelli, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 27, 2018
[Analysis of causes of destruction of labile blood products in health institutions: A multicentric study]A Damais-Cepitelli, S Leo-Kodeli, V Lovi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 19, 2020
Reducing hospital admissions for COVID-19 at a dedicated screening centre in SingaporeG S E Tan, H Ang, C M Manauis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trialP Comella, F De Vita, S Mancarella, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 17, 2007
[Assessment of knowledge in blood transfusion of medical staff in 14 state-run hospitals]H Gouëzec, V Bergoin, V Betbèze, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2015
Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 scoreA Faggiano, A C Carratù, E Guadagno, et al.
Lancet (London, England)|October 16, 1999
Outbreak of Nipah-virus infection among abattoir workers in SingaporeN I Paton, Y S Leo, S R Zaki, et al.
JAMA|July 13, 2000
Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window periodA E Ling, K E Robbins, T M Brown, et al.
International Journal of Oncology|September 2, 2014
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III studyV Lorusso, F Giotta, R Bordonaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trialN Normanno, R Esposito Abate, M Lambiase, et al.
Pageof 29